White Paper / Employee Benefits
How precision medicine is revolutionizing employee benefits
Hero Image

This four-part white paper series examines the role of genetic testing in employee benefits. The goal of the series is to help employee benefits professionals understand the complex and evolving topic of precision medicine and to provide a framework for determining whether these new capabilities in medicine should be considered in crafting an employee benefits strategy. Genetic testing and precision medicine is a rapidly emerging and exciting area that will likely challenge the employee benefits industry for decades, so this white paper series will serve as a starting point to shedding light on the trend.

Part I of IV explores how genetic testing is revolutionizing medical care and sets the stage for the next three papers in the series.

Part II of IV explores pharmacogenomics, a subset of precision medicine and further defined as the study of how genes affect a person’s response to drugs.

Part III of IV takes a closer look at how cancer genomics is radically changing cancer diagnosis and treatment.

Part IV of IV reviews current policy addressing genomic information privacy as it relates to employers, and discusses some of the legal and ethical considerations of this emerging area of medicine.

Part 1


Part 2


Part 3


Part 4


Request this White Paper

Please fill out all of the forms below to have this white paper(s) emailed directly to you.

Acknowledgment and Acceptance of Terms.
By signing up for our newsletters and updates, you acknowledge that you have read, understand, and agree to our Terms of Use and to the use of your Personal Information in accordance with our Privacy Notice and Cookie Policy.

Your request was successfully sent. You should receive your email shortly.

< Back to Insights & Publications
Discover more Insights & Publications  |  Read more in the Lockton Newsroom  |  See our Client Stories
Read more in the Lockton Newsroom
See our Client Stories